Projects per year
Personal profile
Biography
Dr Brad Broughton has an emerging profile in both the national and international cardiovascular community. Brad is currently a Foundation for High Blood Pressure Research Fellow and is a senior member of the Vascular Biology and Immunopharmacology Group in the Department of Pharmacology. He is a member of two Editorial Boards (ISRN Stroke and Physiology Journal) and is a Chief Investigator on a NHMRC Project Grant and Grant-in-aid from the National Heart Foundation.
Over the past 12 years, Brad's research has contributed to our knowledge of reactive oxygen species, calcium, apoptosis, oestrogen, Rho kinase and nitric oxide signalling in the systemic, pulmonary and cerebral circulations. His studies have elucidated physiological mechanisms in vivo and in vitro, identified gender differences, as well as abnormalities in diseases including stroke, pulmonary hypertension and atherosclerosis. The primary focus of his current research is to advance our understanding of mechanisms that contribute to brain damage after stroke, develop safe and effective stroke therapies and identify novel imaging agents that detect cell loss in the brain following stroke.
Research area keywords
- Stroke
- Pulmonary Hypertension
- Stem cells
- Exosomes
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Collaborations and top research areas from the last five years
Projects
- 9 Finished
-
Delivering a novel cell free therapy to improve stroke outcomes
Broughton, B. (Primary Chief Investigator (PCI)), Lim, R. (Chief Investigator (CI)) & Sobey, C. G. (Chief Investigator (CI))
National Heart Foundation of Australia
1/01/21 → 31/12/22
Project: Research
-
Development of a first-in-class neuroprotective drug for protecting the brain after stroke
King, G. F. (Primary Chief Investigator (PCI)), Widdop, R. (Chief Investigator (CI)), Broughton, B. (Chief Investigator (CI)), Rash, L. D. (Chief Investigator (CI)) & Smith, M. T. (Chief Investigator (CI))
1/01/19 → 31/12/21
Project: Research
-
Where have all the stem cells gone? Preliminary in vivo MRI study to track iron-oxide nanoparticle-labelled stem cells
Lim, R. (Primary Chief Investigator (PCI)), Jenkin, G. (Chief Investigator (CI)), McDonald, C. (Chief Investigator (CI)), Bhakoo, K. (Chief Investigator (CI)), Sobey, C. (Chief Investigator (CI)), Broughton, B. (Chief Investigator (CI)), Sievert, W. (Chief Investigator (CI)), Vreys, R. (Chief Investigator (CI)) & Hodge, A. (Chief Investigator (CI))
Agilent Technologies (Australia), Monash University – Internal University Contribution
1/12/14 → 31/12/14
Project: Research
-
Using amnion epithelial stem cells to treat stroke
Broughton, B. (Primary Chief Investigator (PCI))
1/01/14 → 31/12/14
Project: Research
-
How Does G Protein-Coupled Receptor 30 (GPR30) Affect Stroke Outcome?
Broughton, B. (Primary Chief Investigator (PCI))
1/01/12 → 31/12/13
Project: Research
-
Corrigendum to “Simultaneous late-gadolinium enhancement and T1 mapping of fibrosis and a novel cell-based combination therapy in hypertensive mice,”(Biomedicine & Pharmacotherapy, (2023), 158, C, (114069), (S0753332222014585), 10.1016/j.biopha.2022.114069)
Li, Y., Zheng, G., Salimova, E., Broughton, B. R. S., Ricardo, S. D., de Veer, M. & Samuel, C. S., Mar 2026, In: Biomedicine and Pharmacotherapy. 196, 1 p., 119143.Research output: Contribution to journal › Comment / Debate › Other › peer-review
Open Access -
Gut bacteria presence in the brain is increased after ischemic stroke in mice
Peh, A. (Leading Author), Dinakis, E., Nakai, M., Muralitharan, R. R., Rupasinghe, S., Wilson, J. L., Wong, C. H. Y., Jama, H. A., Barker, C. M. O., Modarresi, M., Kemp-Harper, B. K., Zheng, T., Marques, F. Z. (Leading Author) & Broughton, B. R. S. (Leading Author), 2026, In: Gut Microbes. 18, 1, 17 p., 2617694.Research output: Contribution to journal › Article › Research › peer-review
Open Access6 Link opens in a new tab Citations (Scopus) -
Content and delivery preferences for information to support the management of high blood pressure
Chapman, N., Marques, F. Z., Picone, D. S., Adji, A., Broughton, B. R. S., Dinh, Q. N., Gabb, G., Lambert, G. W., Mihailidou, A. S., Nelson, M. R., Stowasser, M., Schlaich, M., Schultz, M. G., Mynard, J. P. & Climie, R. E., Jan 2024, In: Journal of Human Hypertension. 38, 1, p. 70-74 5 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access5 Link opens in a new tab Citations (Scopus) -
Hi1a Improves Sensorimotor Deficit following Endothelin-1-Induced Stroke in Rats but Does Not Improve Functional Outcomes following Filament-Induced Stroke in Mice
Knezic, A., Budusan, E., Saez, N. J., Broughton, B. R. S., Rash, L. D., King, G. F., Widdop, R. E. & McCarthy, C. A., 12 Apr 2024, In: ACS Pharmacology and Translational Science. 7, 4, p. 1043-1054 12 p.Research output: Contribution to journal › Article › Research › peer-review
6 Link opens in a new tab Citations (Scopus) -
Induced pluripotent stem cell-derived mesenchymal stem cells reverse bleomycin-induced pulmonary fibrosis and related lung stiffness
Chakraborty, A., Wang, C., Hodgson-Garms, M., Broughton, B. R. S., Frith, J. E., Kelly, K. & Samuel, C. S., Sept 2024, In: Biomedicine & Pharmacotherapy. 178, 16 p., 117259.Research output: Contribution to journal › Article › Research › peer-review
Open Access19 Link opens in a new tab Citations (Scopus)